Bisphosphonate induced osteonecrosis of the jaws: Unravelling uncertainty in disease causality

Author： Kelleher Fergal C. McKenna Malachi Collins Conor Brady Garrett Collins Ian Crown John

ISSN： 0284-186X

Source： Acta Oncologica, Vol.46, Iss.5, 2007-01, pp. : 702-704

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

By Walter Christian Grötz Knut Kunkel Martin Al-Nawas Bilal

Supportive Care in Cancer, Vol. 15, Iss. 2, 2007-02 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite

Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 439-442

Spandidos Publications

Access to resources Recommend Favorite

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

By Guarneri Valentina

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Comparative serum proteome expression of the steroid-induced femoral head osteonecrosis in adults

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 77-83

Spandidos Publications

Access to resources Recommend Favorite

Bisphosphonate Induced Growth Inhibition of Breast Cancer Cells is Augmented by p38 Inhibition

By Merrell M.

Breast Cancer Research and Treatment, Vol. 81, Iss. 3, 2003-10 ,pp. : 231-241

Springer Publishing Company

Access to resources Recommend Favorite